Coronado readies IND for Crohn's treatment; Aastrom reaches agreement on SPA for critical limb ischemia study;

@FierceBiotech: Nonprofit poised to reap rewards from Vertex's pioneering CF drug. Article | Follow @FierceBiotech

@JohnCFierce: Under pressure to speed things up, FDA Commissioner Margaret Hamburg is looking to loosen conflict rules for adcomm members. Report | Follow @JohnCFierce

@RyanMFierce: Icon's buyout of clinical tech firm Firecrest motivated by improving trials time lines, efficiency. Story | Follow @RyanMFierce

> Fresh from raising $25.8 million, New York-based Coronado Biosciences says it plans to file an IND with the FDA on a new treatment for Crohn's disease. Report

> Aastrom Biosciences has reached an agreement with the FDA on a Special Protocol Assessment for a Phase III trial of ixmyelocel-T in patients with critical limb ischemia who have no other treatment options. Release

> Australia's CSL Limited has forged a commercial license agreement with Selexis for the preclinical development of an antibody scheduled to enter Phase I next year. CSL release

> In a newly announced strategic partnership, Debiopharm says it will trust INC Research with the management of a clinical study linked to an important project in its pipeline. Both parties have also agreed on a "framework partnership" for future clinical studies. Release

Pharma News

@FiercePharma: Will pharma fight the Express-Medco deal? Piece | Follow @FiercePharma

> Eyes on 2012, GSK pledges more cost cuts. Article

> Novo faces sales-rep action on OT pay. Report

Manufacturing News

> Fictional "Spenditol" gives appearance of feelings of relief, unpleasant side effects. Piece

> Rx-360 concludes pilot; begins sharing of supplier audits. News

> For J&J/McNeil no exec blame for recalls, panel says. Report

> Novartis productivity boss seeks procurement's full potential. Article

> Teva supply chain gets a boost from social media. Story

> Hong Kong tips off Vietnam about contaminated GSK drug. More

Biotech Research News

> Researchers detract last year's discovery of longevity genes. Article

> Enzyme insights could lead to better sunburn treatments. Story

> Genetic map of American Americans gives clues to diseases in all populations. Report

> UK scientists urge regulations of animal/human gene experiments. Item

And Finally... Using new technology, scientists say they have found the brain's on/off switch for aggression. Story

Suggested Articles

No biohazardous substances were in the room where the explosion happened, according to the Russian virology center.

Merck has a shot at becoming the first company to receive clearance to sell a vaccine against the virus in the U.S.

Acceleron has chalked up another phase 2 flop as its pipeline thins a little more.